MYLAN 217 250 (Tolazamide 250 mg)
Pill with imprint MYLAN 217 250 is White, Round and has been identified as Tolazamide 250 mg. It is supplied by Mylan Pharmaceuticals Inc..
Tolazamide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Tolazamide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 217 250
Tolazamide
- Imprint
- MYLAN 217 250
- Strength
- 250 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Sulfonylureas
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-0217 | Mylan Pharmaceuticals Inc. |
| 68084-0556 | Amerisource Health Services |
More about tolazamide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Drug class: sulfonylureas
Consumer resources
- Other brands
- Tolinase
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.